|
|
Pegylated Interferon Alpha-2a Advantageous in Dialysis Patients With Hepatitis C
|
| Link ID |
4610 |
| Title |
Pegylated Interferon Alpha-2a Advantageous in Dialysis Patients With Hepatitis C |
| Url |
http://www.medscape.com/viewarticle/572585?src=rss |
| Description |
Once-weekly treatment with pegylated interferon alpha-2a is both more effective and safer than standard interferon alpha-2a three times a week for interferon-naive dialysis patients with chronic hepatitis C virus (HCV) infection, according to a report by Taiwanese researchers published in the April issue of Gut. Reuters Health Information |
| Category |
Articles > Gastroenterology |
| Keywords |
|
| Date |
Apr 5, 2008 |
| Contact Name |
|
| Email |
|
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
|
|
Other links at Articles > Gastroenterology |
| 1. |
HCC -- Current Concepts and Considerations
|
|
|
Alex Befeler, MD, explores the latest clinical information regarding hepatocellular carcinoma, as framed by key data presented at AASLD 2007.
Medscape Gastroenterology
|
|
|